Literature DB >> 29463647

β1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination.

Kazi Mokim Ahmed1, Raj K Pandita2, Dharmendra Kumar Singh2, Clayton R Hunt2, Tej K Pandita1.   

Abstract

The molecular mechanisms underlying resistance to radiotherapy in breast cancer cells remain elusive. Previously, we reported that elevated β1-integrin is associated with enhanced breast cancer cell survival postirradiation, but how β1-integrin conferred radioresistance was unclear. Ionizing radiation (IR) induced cell killing correlates with the efficiency of DNA double-strand break (DSB) repair, and we found that nonmalignant breast epithelial (S1) cells with low β1-integrin expression have a higher frequency of S-phase-specific IR-induced chromosomal aberrations than the derivative malignant breast (T4-2) cells with high β1-integrin expression. In addition, there was an increased frequency of IR-induced homologous recombination (HR) repairosome focus formation in T4-2 cells compared with that of S1 cells. Cellular levels of Rad51 in T4-2 cells, a critical factor in HR-mediated DSB repair, were significantly higher. Blocking or depleting β1-integrin activity in T4-2 cells reduced Rad51 levels, while ectopic expression of β1-integrin in S1 cells correspondingly increased Rad51 levels, suggesting that Rad51 is regulated by β1-integrin. The low level of Rad51 protein in S1 cells was found to be due to rapid degradation by the ubiquitin proteasome pathway (UPP). Furthermore, the E3 ubiquitin ligase RING1 was highly upregulated in S1 cells compared to T4-2 cells. Ectopic β1-integrin expression in S1 cells reduced RING1 levels and increased Rad51 accumulation. In contrast, β1-integrin depletion in T4-2 cells significantly increased RING1 protein levels and potentiated Rad51 ubiquitination. These data suggest for the first time that elevated levels of the extracellular matrix receptor β1-integrin can increase tumor cell radioresistance by decreasing Rad51 degradation through a RING1-mediated proteasomal pathway.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HR; Rad51; breast cancer; homologous recombination; radioresistance; β1-integrin

Mesh:

Substances:

Year:  2018        PMID: 29463647      PMCID: PMC5902589          DOI: 10.1128/MCB.00672-17

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells.

Authors:  F Aoudjit; K Vuori
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

2.  Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis.

Authors:  Iris Eke; Katja Storch; Mechthild Krause; Nils Cordes
Journal:  Cancer Res       Date:  2013-08-15       Impact factor: 12.701

3.  The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Kevin S Fay; Evan D Staszewski; Zhao-Zhu Zeng; Donna L Livant
Journal:  Breast Cancer Res Treat       Date:  2010-03-19       Impact factor: 4.872

Review 4.  Histone modifications and DNA double-strand break repair after exposure to ionizing radiations.

Authors:  Clayton R Hunt; Deepti Ramnarain; Nobuo Horikoshi; Puneeth Iyengar; Raj K Pandita; Jerry W Shay; Tej K Pandita
Journal:  Radiat Res       Date:  2013-02-01       Impact factor: 2.841

5.  Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-05       Impact factor: 11.205

6.  Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.

Authors:  Margarita Sánchez-Beato; Esther Sánchez; Joaquín González-Carreró; Manuel Morente; Ana Díez; Lydia Sánchez-Verde; María Carmen Martín; Juan C Cigudosa; Miguel Vidal; Miguel A Piris
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

7.  53BP1 regulates DSB repair using Rif1 to control 5' end resection.

Authors:  Michal Zimmermann; Francisca Lottersberger; Sara B Buonomo; Agnel Sfeir; Titia de Lange
Journal:  Science       Date:  2013-01-10       Impact factor: 47.728

8.  A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin.

Authors:  David A Alagpulinsa; Srinivas Ayyadevara; Robert Joseph Shmookler Reis
Journal:  Front Oncol       Date:  2014-10-30       Impact factor: 6.244

9.  CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle.

Authors:  Maximina H Yun; Kevin Hiom
Journal:  Nature       Date:  2009-04-08       Impact factor: 49.962

10.  A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.

Authors:  Anand D Jeyasekharan; Yang Liu; Hiroyoshi Hattori; Venkat Pisupati; Asta Bjork Jonsdottir; Eeson Rajendra; Miyoung Lee; Elayanambi Sundaramoorthy; Simon Schlachter; Clemens F Kaminski; Yaara Ofir-Rosenfeld; Ko Sato; Jane Savill; Nabieh Ayoub; Ashok R Venkitaraman
Journal:  Nat Struct Mol Biol       Date:  2013-09-08       Impact factor: 15.369

View more
  12 in total

Review 1.  Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

2.  H. pylori infection alters repair of DNA double-strand breaks via SNHG17.

Authors:  Taotao Han; Xiaohui Jing; Jiayu Bao; Lianmei Zhao; Aidong Zhang; Renling Miao; Hui Guo; Baoguo Zhou; Shang Zhang; Jiazeng Sun; Juan Shi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 3.  Budding yeast Rad51: a paradigm for how phosphorylation and intrinsic structural disorder regulate homologous recombination and protein homeostasis.

Authors:  Tai-Ting Woo; Chi-Ning Chuang; Ting-Fang Wang
Journal:  Curr Genet       Date:  2021-01-12       Impact factor: 3.886

4.  Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response.

Authors:  Shaoli Das; Kevin Camphausen; Uma Shankavaram
Journal:  Front Oncol       Date:  2019-10-25       Impact factor: 6.244

5.  Cell adhesion to collagen promotes leukemia resistance to doxorubicin by reducing DNA damage through the inhibition of Rac1 activation.

Authors:  Dalila Naci; Sofiane Berrazouane; Frédéric Barabé; Fawzi Aoudjit
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

6.  PUMA facilitates EMI1-promoted cytoplasmic Rad51 ubiquitination and inhibits DNA repair in stem and progenitor cells.

Authors:  Jin Wook Kang; Zhiyan Zhan; Guangzhen Ji; Youzhou Sang; Daohong Zhou; Yanxin Li; Haizhong Feng; Tao Cheng
Journal:  Signal Transduct Target Ther       Date:  2021-03-31

7.  The Valproate Mediates Radio-Bidirectional Regulation Through RFWD3-Dependent Ubiquitination on Rad51.

Authors:  Guochao Liu; David Lim; Zuchao Cai; Wenwen Ding; Zhujun Tian; Chao Dong; Fengmei Zhang; Gongshe Guo; Xiaowei Wang; Pingkun Zhou; Zhihui Feng
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

8.  Depletion of DNA damage binding protein 2 sensitizes triple-negative breast cancer cells to poly ADP-ribose polymerase inhibition by destabilizing Rad51.

Authors:  Lin Zhao; Cheng-Shuai Si; Yue Yu; Jian-Wei Lu; Yan Zhuang
Journal:  Cancer Sci       Date:  2019-10-06       Impact factor: 6.716

9.  Collective cancer invasion forms an integrin-dependent radioresistant niche.

Authors:  Anna Haeger; Stephanie Alexander; Manon Vullings; Fabian M P Kaiser; Cornelia Veelken; Uta Flucke; Gudrun E Koehl; Markus Hirschberg; Michael Flentje; Robert M Hoffman; Edward K Geissler; Stephan Kissler; Peter Friedl
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

10.  c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair.

Authors:  Sara Sofia Deville; Luis Fernando Delgadillo Silva; Anne Vehlow; Nils Cordes
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.